Blueprint Medicines Corp logo

Blueprint Medicines Corp

FRA:2L9 (USA)  
€ 96.00 (-1.96%) Jun 18
At Loss
P/B:
20.92
Market Cap:
€ 6.22B ($ 6.68B)
Enterprise V:
€ 5.93B ($ 6.36B)
Volume:
-
Avg Vol (2M):
158.00
Trade In:

Blueprint Medicines Corp Valuation Measures